WINTON GROUP Ltd - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 139 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.5%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$244,000
-62.0%
5,431
-83.5%
0.01%
-38.1%
Q3 2020$642,000
-5.9%
32,854
-14.9%
0.02%
+16.7%
Q2 2020$682,000
+155.4%
38,611
+2.2%
0.02%
+157.1%
Q1 2020$267,000
-57.8%
37,783
-58.0%
0.01%
-22.2%
Q4 2019$633,000
+41.9%
89,856
+142.0%
0.01%
+80.0%
Q3 2019$446,00037,1240.01%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders